You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Does Gender Identity Affect Psychopathology?

  • Authors: News Author: Batya Swift Yasgur, MA, LSW; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 12/9/2022
  • Valid for credit through: 12/9/2023, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for psychiatrists, pediatricians, physician assistants, family medicine/primary care clinicians, internists, nurses, and other members of the health care team for transgender and gender-diverse patients with mental health issues.

The goal of this activity is for learners to be better able to compare diagnostic profiles of transgender and gender diverse and cisgender patients presenting for treatment at a partial hospital program, including frequency of posttraumatic stress disorder, borderline personality disorder major depressive disorder, and generalized anxiety disorder based on a study using semistructured interviews administered by professionals.

Upon completion of this activity, participants will:

  • Assess the diagnostic profiles of transgender and gender-diverse compared with cisgender patients presenting for treatment at a partial hospital program, based on a study using semistructured interviews administered by professionals
  • Evaluate the clinical implications of diagnostic profiles of transgender and gender-diverse compared with cisgender patients presenting for treatment at a partial hospital program, based on a study using semistructured interviews administered by professionals
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Batya Swift Yasgur, MA, LSW

    Freelance writer, Medscape

    Disclosures

    Batya Swift Yasgur, MA, LSW, has no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has the following relevant financial relationships:
    Formerly owned stocks in: AbbVie Inc.

Editor/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 12/09/2023. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Does Gender Identity Affect Psychopathology?

Authors: News Author: Batya Swift Yasgur, MA, LSW; CME Author: Laurie Barclay, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 12/9/2022

Valid for credit through: 12/9/2023, 11:59 PM EST

processing....

Clinical Context

Transgender and gender-diverse (TGD) individuals have high rates of psychopathology both overall and compared with cisgender persons. Nearly all evidence to date has been limited by reliance on self-reported, unstructured measures and assessment of isolated psychiatric symptom domains, which limits understanding of the mental health needs of TGD individuals.

Identifying differences in diagnostic profiles between TGD and cisgender partial hospital patients could provide additional information about the psychiatric needs of TGD patients in clinical settings. Previous literature has shown the importance of comprehensive, structured, assessments rather than relying on self-report.

Study Synopsis and Perspective

TGD individuals with mental illness appear to have higher rates of posttraumatic stress disorder (PTSD) and borderline personality disorder (BPD) compared with their cisgender counterparts, new research shows.

Although mood disorders, depression, and anxiety were the most common diagnoses in both TGD and cisgender patients, "when we compared the diagnostic profiles [of TGD patients] to those of cisgender patients, we found an increased prevalence of PTSD and BPD," study investigator Mark Zimmerman, MD, professor of psychiatry and human behavior, Brown University, Providence, Rhode Island, told Medscape Medical News.

"What we concluded is that psychiatric programs that wish to treat TGD patients should either have or should develop expertise in treating PTSD and BPD, not just mood and anxiety disorders," Dr Zimmerman said.

The study was published online September 26 in the Journal of Clinical Psychiatry.

'Piecemeal Literature'

TGD individuals "experience high rates of various forms of psychopathology in general and when compared with cisgender persons," the investigators note.

They point out that most empirical evidence has relied on the use of brief, unstructured psychodiagnostic assessment measures and assessment of a "limited constellation of psychiatric symptom domains," resulting in a "piecemeal literature wherein each piece of research documents elevations in one--or a few--diagnostic domains."

Studies pointing to broader psychosocial health variables have often relied on self-reported measures. In addition, in studies that used a structured interview approach, none "used a formal clinical interview procedure for the assessment of psychiatric diagnoses," and most focused only on a "limited number of psychiatric conditions based on self-reports of past diagnosis."

The goal of the current study was to use semistructured interviews administered by professionals to compare the diagnostic profiles of a samples of TGD and cisgender patients who presented presenting for treatment at a single naturalistic, clinically acute setting--a partial hospital program.

Dr Zimmerman said that there was an additional motive for conducting the study. "There has been discussion in the field as to whether or not [TGD] individuals all have borderline personality disorder, but that hasn't been our clinical impression."

Rather, Dr Zimmerman and colleagues believe that TGD people "may have had more difficult childhoods and more difficult adjustments in society because of societal attitudes and have to deal with that stress, whether it be microaggressions or overt bullying and aggression," he said. The study was designed to investigate this issue.

In addition, studies conducted in primary care programs in individuals seeking gender-affirming surgery have "reported a limited number of psychiatric diagnoses, but we were wondering whether, amongst psychiatric patients specifically, there were differences in diagnostic profiles between transgender and gender diverse patients and cisgender patients. If so, what might the implications be for providing care for this population?" Dr Zimmerman added.

TGD Not Synonymous With Borderline

To investigate, the researchers administered semistructured diagnostic interviews for Diagnostic and Statistical Manual of Mental Disorders, fourth edition, disorders to 2212 psychiatric patients (66.0% cisgender women, 30.8% cisgender men, 3.1% TGD; mean [SD] age, 36.7 [14.4] years) presenting to the Rhode Island Hospital Department of Psychiatry Partial Hospital Program between April 2014 and January 2021.

Patients also completed a demographic questionnaire including their assigned sex at birth and their current gender identity.

Most patients (44.9%) were single, followed by 23.5% who were married, 14.1% living in a relationship as if married, 12.0% divorced, 3.6% separated, and 1.9% widowed.

Almost three quarters of participants (73.2%) identified as White, followed by Hispanic (10.7%), Black (6.7%), "other" or a combination of racial/ethnic backgrounds (6.6%), and Asian (2.7%).

There were no differences between cisgender and TGD groups in terms of race or education, but the TGD patients were significantly younger compared with their cisgender counterparts and were significantly more likely to have never been married.

The average number of psychiatric diagnoses in the sample was 3.05 (standard deviation, 1.73), with TGD patients having a larger number of psychiatric diagnoses than their cisgender peers (an average of 3.54 ± 1.88 vs 3.04 ± 1.72, respectively; t=2.37; P=.02).

Major depressive disorder (MDD) and generalized anxiety disorder (GAD) were the most common disorders among both cisgender and TGD patients. However, after controlling for age, the researchers found that TGD patients were significantly more likely than cisgender patients to be diagnosed with PTSD and BPD (both Ps<.05)

Disorder

Cisgender

TGD

OR (95% CI)

MDD

59.0%

46.4%

0.62 (0.38-1.01)

GAD

52.4%

56.5%

1.06 (0.65-1.72)

PTSD

28.1%

42.0%

1.82 (1.11-2.98)

BPD

18.8%

36.2%

1.87 (1.12-3.11)

"Of note, only about one-third of the TGD individuals were diagnosed with BPD, so it is important to realize that [TGD] identity is not synonymous with BPD, as some have suggested," noted Dr Zimmerman, who is also the director of the Outpatient Division at the Partial Hospital Program, Rhode Island Hospital.

A Representative Sample?

Commenting for Medscape Medical News, Jack Drescher, MD, distinguished life fellow of the American Psychiatric Association and clinical professor of psychiatry, Columbia University, New York City, called the findings "interesting" but noted that a limitation of the study is that it included "a patient population with likely more severe psychiatric illness, since they were all day hospital patients."

The question is whether similar findings would be obtained in a less severely ill population, said Dr Drescher, who is also a senior consulting analyst for sexuality and gender at Columbia University and was not involved with the study. "The patients in the study may not be representative of the general population, either cisgender or transgender."

Dr Drescher was "not surprised" by the finding regarding PTSD because the finding "is consistent with our understanding of the kinds of traumas that transgender people go through in day-to-day life."

He noted that some people misunderstand the diagnostic criterion in BPD of identity confusion and think that because people with gender dysphoria may be confused about their identity, it would mean that all people who are transgender have borderline personality disorder, "but that's not true."

Dr Zimmerman agreed. "The vast majority of individuals with BPD do not have a transgender or gender-diverse identity, and TGD should not be equated with BPD," he said.

No source of study funding. Dr Zimmerman and coauthors and Dr Drescher have disclosed no relevant financial relationships.

J Clin Psychiatry. Published online September 26, 2022.[1]

Study Highlights

  • Between April 2014 and January 2021, 2,212 psychiatric patients underwent semistructured diagnostic interviews for Diagnostic and Statistical Manual of Mental Disorders, fourth edition, disorders and completed a demographic questionnaire.
  • Mean age was 36.7±14.4 years; 66.0% were cisgender women, 30.8% cisgender men, 3.1% TGD.
  • Cisgender and TGD individuals did not differ in race and education, but TGD individuals were significantly younger and more likely to have never married.
  • TGD patients (n=69) had, on average, more diagnoses than cisgender patients (3.54±1.88 vs 3.04±1.72; t=2.37; P=.02).
  • Among both cisgender and TGD patients, MDD and GAD were the most common disorders.
  • TGD patients were significantly more likely to be diagnosed with PTSD and BPD than cisgender patients (P<.05), after controlling for age.
  • For TGD vs cisgender, odds ratios (95% CI) were: MDD, 0.62 (0.38-1.01; 46.4% vs 59.0%); GAD, 1.06 (0.65-1.72; 56.5% vs 52.4%); PTSD, 1.82 (1.11-2.98; 42.0% vs 28.1%); and BPD, 1.87 (1.12-3.11; 36.2% vs 18.8%).
  • The investigators concluded that this first study of psychiatric patients using semistructured diagnostic interviews to compare the frequency of psychiatric disorders between cisgender and TGD patients has implications for creating gender-inclusive treatment facilities, for working with TGD populations in naturalistic clinical settings, and for future research on TGD psychiatric disparities.
  • Diagnostic profiles of TGD vs cisgender psychiatric patients were similar regarding mood, anxiety, substance use, eating, somatoform, psychotic, impulse control, and adjustment disorders, but TGD patients had significantly higher psychiatric comorbidity (number of psychiatric diagnoses).
  • PTSD and BPD, which are associated with acute or persistent abuse, trauma, and discrimination, were more prevalent in TGD patients, consistent with the stressors they are more likely to encounter in daily life.
  • Although people with gender dysphoria may be confused about their identity, and identity confusion is a diagnostic criterion for BPD, most individuals with BPD do not have TGD and vice versa.
  • Clinicians should therefore not assume that TGD patients are likely to have BPD.
  • Psychiatry programs interested in qualifying as Safe Zones and treating TGD patients should have or develop expertise in treating PTSD and BPD.
  • Study limitations include small TGD sample, lack of data regarding minority stressors and possible lack of generalizability to the general cisgender or transgender population, as the study sample in a single clinical setting included only day hospital patients, likely with more severe psychiatric illness.
  • Future research should examine whether differences in self-identification within the TGD group is associated with different diagnostic profiles.

Clinical Implications

  • PTSD and BPD were more prevalent in TGD than in cisgender patients.
  • Psychiatry programs interested in qualifying as Safe Zones and treating TGD patients should have or develop expertise in treating PTSD and BPD.
  • Implications for the Health Care Team: It is important to ensure routine screening for these disorder domains is available and occurring in clinical settings.

 

Earn Credit

  • Print